1 Cyber-Physical Systems 2 Continuous Bioprocess Control 3 Drug Manufacturing 4 Monoclonal Antibodies 5 Automation
1 Cyber-Physical Systems
2 Continuous Bioprocess Control
3 Drug Manufacturing
4 Monoclonal Antibodies
5 Automation
Lonza Doubles Capacity Adds 200 Jobs in Switzerland!
Lonza expands its Visp facility with two new bioconjugation suites, creating 200 jobs and doubling capacity for antibody-drug conjugates! 🌍🏗️💼📈🌱
Accelerate Drug Development: Pheast’s Game-Changing Method!
🚀 Pheast Therapeutics fast-tracks anti-CD24 treatment development! ⏳ Reduced time to 11 months with flexible parallel processes. 💡 Future projects await! 🌟
Unlocking Antibody Secrets: ML Revolutionizes Manufacturing!
**Excerpt:** 🌟 Discover how ML is revolutionizing antibody distribution analysis! 🔍 Enhance monoclonal production with innovative techniques and save resources! 💡📊
Revolutionizing Antibody Development with Automation Magic!
Unlocking mAb development! 🤖✨ Discover how automation and machine learning enhance efficiency in bioprocessing for biopharma innovation. 🔬🚀
Boosting SARS-CoV-2 Spike Protein Production Strategies!
**Excerpt:** 🌟 Researchers boost SARS-CoV-2 spike protein production! 🧪 Key strategies include aeration, feeding methods, and automation for optimal results. ⚙️🔍
Bioprocessing Breakthroughs: Experts Share Insights!
🌟 Experts dive into bioprocessing challenges, AI's impact, and networking at BPI. Discover trends shaping a dynamic future! 🤖🤝🔗
Revolutionizing Drug Production with Smart Technology!
Excerpt Discover how a new 🌐 cyber-physical system revolutionizes 🛠️ bioprocess control, boosting efficiency 📈 and minimizing waste in drug manufacturing! 🏭
